{"id":"NCT03829969","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","briefTitle":"Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma","officialTitle":"A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Compare Toripalimab Injection (JS001) Combined With Standard Chemotherapy Versus Placebo Combined With Standard Chemotherapy in Treatment of Advanced or Metastatic Esophageal Squamous Cell Cancer (ESCC) Without Previous Systemic Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-01-31","primaryCompletion":"2021-03-22","completion":"2023-09-30","firstPosted":"2019-02-04","resultsPosted":"2024-05-02","lastUpdate":"2025-07-23"},"enrollment":514,"design":{"allocation":"RANDOMIZED","model":"SEQUENTIAL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy"],"interventions":[{"type":"BIOLOGICAL","name":"Toripalimab","otherNames":["JS001, TAB001"]}],"arms":[{"label":"Toripalimab","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is one randomized, double-blind, multi-center, placebo-controlled phase III study. The objective of this study is to compare the effectiveness and safety of JS001 combined with paclitaxel and cisplatin(TP regimen )with placebo combined with TP regimen in patients with advanced or metastatic Esophageal Squamous Cell Carcinoma(ESCC )who have not received systemic chemotherapy previously.","primaryOutcome":{"measure":"PFS((Progression-Free Surviv)","timeFrame":"PFS: up to 2years","effectByArm":[{"arm":"Toripalimab","deltaMin":5.7,"sd":null},{"arm":"Placebo","deltaMin":5.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":93,"n":257},"commonTop":["Blood and lymphatic system disorders","gastrointestinal disors","Metabolism and nutrition disorders","Investigations","General disorders"]}}